The Centers for Medicare & Medicaid Services yesterday announced additional proposed changes to Medicare Advantage and Part D payment policies for calendar year 2019. CMS anticipates the MA plans and Part D sponsors will see an average revenue increase of 1.84%, excluding an expected 3.1% increase in risk scores. In December, CMS proposed changes to the risk adjustment model for aged and disabled beneficiaries enrolled in MA Part C plans beginning in calendar year 2019, as required by the 21st Century Cures Act. CMS must phase in the new risk adjustment model over four years and proposes using a 25% to 75% blend of the new and previous risk adjustment model for 2019. The agency also proposes to update the MA risk adjustment models for end-stage renal disease and Part D plans in 2019, among other changes. In addition, CMS proposes several changes to combat opioid overuse, including adding hard safety edits at the point-of-sale that limit supply to seven days. AHA will provide more information on the proposed changes to members soon. CMS will accept comments on the new notice through March 5 and on the December notice through March 2, and expects to publish final notices on April 2.

Related News Articles

Perspective
Two weeks ago, I wrote about the
Headline
The U.S. Court of Appeals for the District of Columbia Circuit reversed the voiding of a rule that included Medicare and private insurance payments when…
Headline
The Health Resources and Services Administration yesterday awarded 80 rural consortia $1 million each to help prevent, treat and support recovery for patients…
Headline
The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption…
Headline
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the…
Headline
Medicare will cover nationally Chimeric Antigen Receptor T-cell therapies approved by the Food and Drug Administration to treat certain cancers, as well as off…